FDA Inspection 1110062 — Supriya Lifescience Limited
The FDA completed an inspection of Supriya Lifescience Limited on October 3, 2019 in Tal Khed, Dist Ratnagiri. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 3, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tal Khed, Dist Ratnagiri (India)